97 related articles for article (PubMed ID: 20102445)
1. Fabry disease and G6PD in three family members with priapism: is the nitric oxide pathway to blame?
Backenroth R; Landau EH; Goren M; Raas-Rothschild A
J Sex Med; 2010 Apr; 7(4 Pt 1):1588-91. PubMed ID: 20102445
[TBL] [Abstract][Full Text] [Related]
2. A novel GLA mutation in a Fabry family with glucose-6-phosphate dehydrogenase deficiency.
Pisani A; Visciano B; Russo R; Mozzillo GR; Porto C; De Maggio I; Russo R; Pontarelli G; Villani GR; Cianciaruso B; Di Natale P
J Nephrol; 2012; 25(4):582-5. PubMed ID: 22307442
[TBL] [Abstract][Full Text] [Related]
3. [Priapism: a severe paediatric complication of Fabry disease].
Labarthe F; de Bodman C; Maruani A; Szwarc C; Froissart R; Lorette G; Lardy H
Rev Med Interne; 2010 Dec; 31 Suppl 2():S217-9. PubMed ID: 21211667
[TBL] [Abstract][Full Text] [Related]
4. Glucose-6-phosphate dehydrogenase deficiency associated stuttering priapism: report of a case.
Finley DS
J Sex Med; 2008 Dec; 5(12):2963-6. PubMed ID: 18823322
[TBL] [Abstract][Full Text] [Related]
5. Glucose-6-phosphate dehydrogenase deficiency: an etiology for idiopathic priapism?
Burnett AL; Bivalacqua TJ
J Sex Med; 2008 Jan; 5(1):237-40. PubMed ID: 17971109
[TBL] [Abstract][Full Text] [Related]
6. Priapism and glucose-6-phosphate dehydrogenase deficiency: An underestimated correlation?
De Rose AF; Mantica G; Tosi M; Bovio G; Terrone C
Arch Ital Urol Androl; 2016 Oct; 88(3):235-236. PubMed ID: 27711102
[TBL] [Abstract][Full Text] [Related]
7. A novel small insertion mutation, C.1030_1031ins (T) in α-galactosidase A leads to renal variant fabry disease.
Choi JS; Kim CS; Park JW; Bae EH; Ma SK; Choi YD; Kim GH; Yoo HW; Kim SW
Ren Fail; 2012; 34(3):390-3. PubMed ID: 22260214
[TBL] [Abstract][Full Text] [Related]
8. Vasculopathy in patients with Fabry disease: current controversies and research directions.
Rombach SM; Twickler TB; Aerts JM; Linthorst GE; Wijburg FA; Hollak CE
Mol Genet Metab; 2010 Feb; 99(2):99-108. PubMed ID: 19900828
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor (VEGF-a) in Fabry disease: association with cutaneous and systemic manifestations with vascular involvement.
Zampetti A; Gnarra M; Borsini W; Giurdanella F; Antuzzi D; Piras A; Smaldone C; Pieroni M; Cadeddu C; de Waure C; Feliciani C
Cytokine; 2013 Mar; 61(3):933-9. PubMed ID: 23332617
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of Fabry disease via analysis of family history.
Laney DA; Fernhoff PM
J Genet Couns; 2008 Feb; 17(1):79-83. PubMed ID: 18172746
[TBL] [Abstract][Full Text] [Related]
11. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype.
Nakao S; Kodama C; Takenaka T; Tanaka A; Yasumoto Y; Yoshida A; Kanzaki T; Enriquez AL; Eng CM; Tanaka H; Tei C; Desnick RJ
Kidney Int; 2003 Sep; 64(3):801-7. PubMed ID: 12911529
[TBL] [Abstract][Full Text] [Related]
12. Fabry disease and vascular risk factors: future strategies for patient-based studies and the knockout murine model.
Moore DF; Gelderman MP; Fuhrmann SR; Schiffmann R; Brady RO; Goldin E
Acta Paediatr Suppl; 2006 Apr; 95(451):69-71. PubMed ID: 16720469
[TBL] [Abstract][Full Text] [Related]
13. Red cell glucose 6-phosphate dehydrogenase deficiency in the northern region of Turkey: is G6PD deficiency exclusively a male disease?
Albayrak C; Albayrak D
Pediatr Hematol Oncol; 2015 Mar; 32(2):85-91. PubMed ID: 25116429
[TBL] [Abstract][Full Text] [Related]
14. Fabry disease: molecular genetics of the inherited nephropathy.
Desnick RJ; Astrin KH; Bishop DF
Adv Nephrol Necker Hosp; 1989; 18():113-27. PubMed ID: 2564247
[TBL] [Abstract][Full Text] [Related]
15. Ischaemic Priapism and Glucose-6-Phosphate Dehydrogenase Deficiency: A Mechanism of Increased Oxidative Stress?
Morrison BF; Thompson EB; Shah SD; Wharfe GH
West Indian Med J; 2014 Jul; 63(6):658-60. PubMed ID: 25803385
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and cytochemical evaluation of heterozygote individuals with glucose-6-phosphate dehydrogenase deficiency.
Gurbuz N; Aksu TA; Van Noorden CJ
Acta Histochem; 2005; 107(4):261-7. PubMed ID: 16139339
[TBL] [Abstract][Full Text] [Related]
17. Incidence and molecular characterization of Glucose-6-Phosphate Dehydrogenase deficiency among neonates for newborn screening in Chaozhou, China.
Yang H; Wang Q; Zheng L; Zhan XF; Lin M; Lin F; Tong X; Luo ZY; Huang Y; Yang LY
Int J Lab Hematol; 2015 Jun; 37(3):410-9. PubMed ID: 25440321
[TBL] [Abstract][Full Text] [Related]
18. Fabry disease in patients with end-stage renal failure: the potential benefits of screening.
Bekri S; Enica A; Ghafari T; Plaza G; Champenois I; Choukroun G; Unwin R; Jaeger P
Nephron Clin Pract; 2005; 101(1):c33-8. PubMed ID: 15886492
[TBL] [Abstract][Full Text] [Related]
19. [Fabry disease: data from four families].
Slee PH; van Boven LJ; Slee DS
Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2412-5. PubMed ID: 11145098
[TBL] [Abstract][Full Text] [Related]
20. [Clinical courses of two male siblings on hemodialysis for Fabry disease ].
Itoh K; Tanaka M; Matsushita K; Miyamura N; Nishida K; Araki E; Nonoguchi H; Tomita K
Nihon Jinzo Gakkai Shi; 2005; 47(2):121-7. PubMed ID: 15859134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
